A Multifaceted Telehealth Approach to Enhancing Glycemic Control and Reducing Readmissions in a Diverse Diabetic Population: A Randomized Control Trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 208
- 主要终点
- Hemoglobin A1c
研究概览
简要总结
This study evaluates whether the use of a Continuous Glucose Monitoring (CGM) device combined with a Remote Patient Monitoring (RPM) program can improve blood sugar control and reduce hospital visits among patients with poorly controlled diabetes who have recently been discharged from the hospital.
The study, led by White Plains Hospital (WPH) Cares, will follow 208 patients for 90 days after their discharge. Half of the participants will receive standard care, while the other half will receive a Dexcom G7 CGM device along with support from trained nurses who will monitor their glucose readings daily. The goal is to determine whether this approach helps lower Hemoglobin A1c (HbA1c) levels, reduces hospital readmissions, and improves overall health outcomes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Discharged Home from the WPH Inpatient Setting A1c >= 8.0 within 90 days of discharge >= 18 Years of Age Lives within Westchester County
排除标准
- •<18 Years of Age Patient With Documented Cognitive Impairment or Decisional Incapacity Pregnant or Plans to Become Pregnant in 6 Months Discharge Disposition of Short-term or Long-term Care Facility, Assisted Living Facility, Group Home, Against Medical Advice/Eloped, or Home Hospice Patient or Caregiver Unable to Check Glucose at Home Using a Home Glucometer Lives Outside Westchester County
研究组 & 干预措施
Control Arm -standard of care
Intervention Arm
Continuous glucose monitoring, remote patient monitoring for 90 days
干预措施: Continues glucose monitoring with remote glucose monitoring for 90 days (Device)
结局指标
主要结局
Hemoglobin A1c
时间窗: 90 days
次要结局
- Overall healthcare utilization(90 days)
- 30 days hospital readmissions(30 days)
- Acute care visits related to abnormal glucose reading(30 days)